Sleeping Sickness: Human African Trypanosomiasis (HAT).

From:
Department for International Development
Published
1 January 2009
Document Type:
Briefing
Theme:
Health
Authors:
Drugs For Neglected Diseases Initiative (DND<i>i</i>)

Abstract

This document summarizes the problem of human African trypanosmiasis and describes the work of DNDi and its partners in developing new treatments: the search for new lead compounds, the development of the nitroimidazole fexinizadole as a new trypanocidal drug, and the introduction of nifurtimox-eflornithine combination therapy, the first new treatment developed for sleeping sickness in 25 years.

Citation

4 pp.

Sleeping Sickness: Human African Trypanosomiasis (HAT).

Updates to this page

Published 1 January 2009
Contents